Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Weijie Pharmaceutical is a Chinese pharmaceutical company specializing in the research, development, and large-scale production of Active Pharmaceutical Ingredients (APIs) and high-end pharmaceutical intermediates. Based in Zibo, Shandong, the company operates manufacturing facilities that adhere to international quality standards including GMP. Their product portfolio features significant anti-viral agents, such as Favipiravir, as well as intermediates for cardiovascular, anti-tumor, and anti-diabetic medications. The company serves as a critical supplier in the global pharmaceutical supply chain, exporting products to various international markets while maintaining a strong domestic presence in China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shandong Weijie Pharmaceutical.